What is Immune Therapeutics, Inc. (IMUN)?

Immune Therapeutics, Inc. (IMUN) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of IMUN?

The current price of IMUN is $0.09. Prices are updated in real time on Stocks360.

What is IMUN's price-to-earnings (PE) ratio?

IMUN's trailing twelve-month PE ratio is -0.58, based on current price and earnings per share data available on Stocks360.

What is IMUN's market capitalization?

IMUN's market capitalization is $7,776,734.00, placing it in the small-cap tier.

Immune Therapeutics, Inc. (IMUN)

Stock analysis · OTC · Healthcare · Biotechnology

$0.09

Market Cap

$7.78M

PE (TTM)

-0.58

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.26

Day Range

$0.09 – $0.09

52-wk Range

$0.07 – $1.30

Avg Volume

N/A

Volume

1.83K

Immune Therapeutics, Inc. (IMUN) is a publicly traded company in the Healthcare sector. Latest price: $0.09. Market cap $7.78M. Trailing PE -0.58. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Immune Therapeutics, Inc.

Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters are situated in Orlando, Florida.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.58×
P/S (TTM)	0.00×
P/B	-1.34×
P/FCF (TTM)	-7.19×
EV / EBITDA	-12.94×
EV / Sales	0.00×
Earnings Yield	-171.50%
Free Cash Flow Yield	-13.91%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$8.32M
Net Income (TTM)	-$13.34M
Free Cash Flow (TTM)	-$884.74K
Net Debt	$545.99K
Working Capital	-$3.33M
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	110.65%
Return on Invested Capital	64.01%